Acute Myeloid Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
Not yet recruiting
  • Acute Myeloid Leukemia
  • Oral Azacitidine
  • Placebo
  • Nagoya, Aichi, Japan
  • +17 more
2022-01-05
Jan 5, 2022
D
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Boston, Massachusetts
  • +1 more
2022-01-12
Jan 12, 2022
P
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +42 more
2021-12-29
Dec 29, 2021
U
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
Recruiting
  • Acute Myeloid Leukemia
  • Graz, Austria
  • +59 more
2021-12-29
Dec 29, 2021
G
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Bergamo, Italy
  • +21 more
2021-12-31
Dec 31, 2021
T
Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia - 2021
Completed
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Fairway, Kansas
    University of Kansas Cancer Center - Clinical Research Center
2022-01-12
Jan 12, 2022
I
National Longitudinal Cohort of Hematological Diseases
Recruiting
  • Multiple Myeloma
  • +17 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    2022-01-11
    Jan 11, 2022
    G
    Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia
    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • (no location specified)
    2021-12-31
    Dec 31, 2021
    S
    Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
    Active, not recruiting
    • Acute Myeloid Leukemia
    • +66 more
    • Best Practice
    • +3 more
    • Fullerton, California
      Virginia K Crosson Cancer Center
    2022-01-11
    Jan 11, 2022
    N
    Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine in Patients With Acute Myeloid Leukemia
    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Duarte, California
    • +11 more
    2022-01-12
    Jan 12, 2022
    J
    Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
    Recruiting
    • Acute Myeloid Leukemia
    • Chicago, Illinois
    • +3 more
    2022-01-10
    Jan 10, 2022
    P
    Post Marketing Surveillance (PMS) Study of Mylotarg
    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      2022-01-11
      Jan 11, 2022
      A
      A Randomized Study to Evaluate the Efficacy of 5-Aza for Post-Remission Therapy of AML in Elderly Patients - 2021
      Completed
      • Acute Myeloid Leukemia
      • Vidaza 100 MG Injection
      • Alessandria, AL, Italy
      • +17 more
      2021-12-27
      Dec 27, 2021
      H
      Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
      Active, not recruiting
      Has Results
      • Myelodysplastic Syndrome
      • +3 more
      • Tampa, Florida
      • +5 more
      2022-01-03
      Jan 3, 2022
      S
      The Oronasal Microbiota in Pediatric Oncology Patients
      Recruiting
      • Acute Myeloid Leukemia
      • +2 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        2022-01-10
        Jan 10, 2022
        B
        Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
        Recruiting
        • Acute Myeloid Leukemia
        • CLL-1.CAR T cells
        • Houston, Texas
          Texas Children's Hospital
        2021-12-26
        Dec 26, 2021
        J
        CPX-351 Real-World Effectiveness and Safety Study
        Not yet recruiting
        • Acute Myeloid Leukemia
        • Belfast, United Kingdom
        • +14 more
        2022-01-07
        Jan 7, 2022
        A
        Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
        Recruiting
        • Acute Myeloid Leukemia
        • Los Angeles, California
        • +7 more
        2022-01-07
        Jan 7, 2022
        A
        A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia
        Not yet recruiting
        • Acute Myeloid Leukemia
        • Hematopoietic stem cell transplantation
        • Best chemotherapy treatment
        • Paris, France
          Saint Antoine Hospital - Hematology Department
        2021-12-22
        Dec 22, 2021
        B
        Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
        Recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndrome
        • MultiTAA-specific T cells
        • Houston, Texas
        • +1 more
        2022-01-06
        Jan 6, 2022
        G
        Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
        Recruiting
        • Acute Myeloid Leukemia
        • Bergamo, Italy
        • +7 more
        2021-12-17
        Dec 17, 2021
        L
        Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
        Not yet recruiting
        • Acute Myeloid Leukemia
        • (no location specified)
        2021-12-21
        Dec 21, 2021
        C
        Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML) - 2021
        Completed
        • Acute Myeloid Leukemia
        • Los Angeles, California
        • +8 more
        2022-01-04
        Jan 4, 2022
        F
        Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
        Suspended
        • Acute Leukemia
        • +18 more
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +8 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        2021-12-16
        Dec 16, 2021
        N
        Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
        Recruiting
        • Acute Myeloid Leukemia
        • +6 more
        • Orange, California
        • +8 more
        2022-01-04
        Jan 4, 2022